Fiduciary Trust CO Abb Vie Inc. Transaction History

Fiduciary Trust CO

$6.5 Billion
Q2 2024

A detailed history of Fiduciary Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 299,935 shares of ABBV stock, worth $58.4 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

299,935

Previous 301,516 0.52%

Holding current value

$58.4 Million

Previous $54.9 Million 6.31%

% of portfolio

0.79%

Previous 0.86%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $244,722 - $285,781	-1,581 Reduced 0.52%	299,935 $51.4 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $189,386 - $215,788	1,185 Added 0.39%	301,516 $54.9 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $1.16 Million - $1.31 Million	-8,454 Reduced 2.74%	300,331 $46.5 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $568,291 - $657,881	-4,254 Reduced 1.36%	308,785 $46 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $267,140 - $332,438	-2,016 Reduced 0.64%	313,039 $42.2 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $590,298 - $679,816	-4,082 Reduced 1.28%	315,055 $50.2 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $233,882 - $280,486	-1,691 Reduced 0.53%	319,137 $51.6 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $6,173 - $7,080	-46 Reduced 0.01%	320,828 $43.1 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.44 Million - $1.83 Million	-10,435 Reduced 3.15%	320,874 $49.1 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $2.41 Million - $2.99 Million	-18,289 Reduced 5.23%	331,309 $53.7 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $1.25 Million - $1.58 Million	-11,634 Reduced 3.22%	349,598 $47.3 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $72,564 - $82,371	-682 Reduced 0.19%	361,232 $39 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.92 Million - $2.14 Million	18,241 Added 5.31%	361,914 $40.8 Million
Q1 2021 May 19, 2021	BUY	$102.3 - $112.62 $753,644 - $829,671	7,367 Added 2.19%	343,673 $37.2 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $817,617 - $1.1 Million	10,158 Added 3.11%	336,306 $36 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $877,312 - $1.03 Million	10,212 Added 3.23%	326,148 $28.6 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $867,600 - $1.16 Million	11,825 Added 3.89%	315,936 $31 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $330,756 - $501,467	5,128 Added 1.72%	304,111 $23.2 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $392,747 - $491,411	5,445 Added 1.85%	298,983 $26.5 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $156,568 - $188,239	2,486 Added 0.85%	293,538 $22.2 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $381,454 - $487,587	5,806 Added 2.04%	291,052 $21.2 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $748,720 - $881,207	-9,706 Reduced 3.29%	285,246 $23 Million
Q4 2018 Jan 29, 2019	SELL	$77.85 - $96.01 $414,629 - $511,349	-5,326 Reduced 1.77%	294,952 $27.2 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $835,487 - $928,799	-9,397 Reduced 3.03%	300,278 $28.4 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $850,485 - $1.01 Million	-9,473 Reduced 2.97%	309,675 $28.7 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $448,732 - $600,895	-4,877 Reduced 1.51%	319,148 $30.2 Million
Q4 2017 Jan 29, 2018	SELL	$89.56 - $98.21 $118,487 - $129,931	-1,323 Reduced 0.41%	324,025 $31.3 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $22.7 Million - $29 Million	325,348	325,348 $28.9 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Account

Fiduciary Trust CO Abb Vie Inc. Transaction History